Stifter K - Search Results

1

Synergistic targeting and resistance to PARP inhibition in DNA damage repair-deficient pancreatic cancer.

Gout J, Perkhofer L, Morawe M, Arnold F, Ihle M, Biber S, Lange S, Roger E, Kraus JM, Stifter K, Hahn SA, Zamperone A, Engleitner T, Müller M, Walter K, Rodriguez-Aznar E, Sainz B Jr, Hermann PC, Hessmann E, Müller S, Azoitei N, Lechel A, Liebau S, Wagner M, Simeone DM, Kestler HA, Seufferlein T, Wiesmüller L, Rad R, Frappart PO, Kleger A. Gout J, et al. Among authors: stifter k. Gut. 2021 Apr;70(4):743-760. doi: 10.1136/gutjnl-2019-319970. Epub 2020 Sep 1. Gut. 2021. PMID: 32873698 Free PMC article.

2

Endogenously Expressed Antigens Bind Mammalian RNA via Cationic Domains that Enhance Priming of Effector CD8 T Cells by DNA Vaccination.

Krieger J, Riedl P, Stifter K, Roman-Sosa G, Seufferlein T, Wagner M, Schirmbeck R. Krieger J, et al. Among authors: stifter k. Mol Ther. 2019 Mar 6;27(3):661-672. doi: 10.1016/j.ymthe.2019.01.011. Epub 2019 Jan 22. Mol Ther. 2019. PMID: 30713086 Free PMC article.

3

A tumor-specific neoepitope expressed in homologous/self or heterologous/viral antigens induced comparable effector CD8⁺ T-cell responses by DNA vaccination.

Stifter K, Dekhtiarenko I, Krieger J, Tissot AC, Seufferlein T, Wagner M, Schirmbeck R. Stifter K, et al. Vaccine. 2020 May 6;38(21):3711-3719. doi: 10.1016/j.vaccine.2020.04.003. Epub 2020 Apr 9. Vaccine. 2020. PMID: 32278524 Free article.

4

An Immunological Glance on Pancreatic Ductal Adenocarcinoma.

Melzer MK, Arnold F, Stifter K, Zengerling F, Azoitei N, Seufferlein T, Bolenz C, Kleger A. Melzer MK, et al. Among authors: stifter k. Int J Mol Sci. 2020 May 8;21(9):3345. doi: 10.3390/ijms21093345. Int J Mol Sci. 2020. PMID: 32397303 Free PMC article. Review.

5

IFN-γ treatment protocol for MHC-I^lo/PD-L1⁺ pancreatic tumor cells selectively restores their TAP-mediated presentation competence and CD8 T-cell priming potential.

Stifter K, Krieger J, Ruths L, Gout J, Mulaw M, Lechel A, Kleger A, Seufferlein T, Wagner M, Schirmbeck R. Stifter K, et al. J Immunother Cancer. 2020 Aug;8(2):e000692. doi: 10.1136/jitc-2020-000692. J Immunother Cancer. 2020. PMID: 32868392 Free PMC article.

6

CD8 T cell-mediated depletion of HBV surface-antigen-expressing, bilineal-differentiated liver carcinoma cells generates highly aggressive escape variants.

Qiu N, Srikanth A, Mulaw M, Tharehalli U, Selvachandran S, Wagner M, Seufferlein T, Stifter K, Lechel A, Schirmbeck R. Qiu N, et al. Among authors: stifter k. Oncoimmunology. 2023 May 26;12(1):2215096. doi: 10.1080/2162402X.2023.2215096. eCollection 2023. Oncoimmunology. 2023. PMID: 37261086 Free PMC article.

7

A missing PD-L1/PD-1 coinhibition regulates diabetes induction by preproinsulin-specific CD8 T-cells in an epitope-specific manner.

Schuster C, Brosi H, Stifter K, Boehm BO, Schirmbeck R. Schuster C, et al. Among authors: stifter k. PLoS One. 2013 Aug 19;8(8):e71746. doi: 10.1371/journal.pone.0071746. eCollection 2013. PLoS One. 2013. PMID: 23977133 Free PMC article.

8

Exploring the induction of preproinsulin-specific Foxp3(+) CD4(+) Treg cells that inhibit CD8(+) T cell-mediated autoimmune diabetes by DNA vaccination.

Stifter K, Schuster C, Schlosser M, Boehm BO, Schirmbeck R. Stifter K, et al. Sci Rep. 2016 Jul 11;6:29419. doi: 10.1038/srep29419. Sci Rep. 2016. PMID: 27406624 Free PMC article.

9

LRH-1 agonism favours an immune-islet dialogue which protects against diabetes mellitus.

Cobo-Vuilleumier N, Lorenzo PI, Rodríguez NG, Herrera Gómez IG, Fuente-Martin E, López-Noriega L, Mellado-Gil JM, Romero-Zerbo SY, Baquié M, Lachaud CC, Stifter K, Perdomo G, Bugliani M, De Tata V, Bosco D, Parnaud G, Pozo D, Hmadcha A, Florido JP, Toscano MG, de Haan P, Schoonjans K, Sánchez Palazón L, Marchetti P, Schirmbeck R, Martín-Montalvo A, Meda P, Soria B, Bermúdez-Silva FJ, St-Onge L, Gauthier BR. Cobo-Vuilleumier N, et al. Among authors: stifter k. Nat Commun. 2018 Apr 16;9(1):1488. doi: 10.1038/s41467-018-03943-0. Nat Commun. 2018. PMID: 29662071 Free PMC article.

10

Cationic domains in particle-forming and assembly-deficient HBV core antigens capture mammalian RNA that stimulates Th1-biased antibody responses by DNA vaccination.

Krieger J, Stifter K, Riedl P, Schirmbeck R. Krieger J, et al. Among authors: stifter k. Sci Rep. 2018 Oct 2;8(1):14660. doi: 10.1038/s41598-018-32971-5. Sci Rep. 2018. PMID: 30279478 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page